- United States
- /
- Chemicals
- /
- NYSE:ECL
What Ecolab (ECL)'s Renewed Analyst Support and CDP Double ‘A’ Rating Means For Shareholders
- In recent days, Ecolab has drawn fresh attention as William Blair analyst Tim Mulrooney reiterated a buy rating while short interest in the stock inched higher but remained well below sector averages.
- At the same time, Ecolab’s double ‘A’ score from CDP for water and climate leadership highlights how its sustainability profile is becoming a core part of the investment story.
- Next, we’ll examine how Ecolab’s renewed analyst support and CDP double ‘A’ rating may influence its existing investment narrative.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Ecolab Investment Narrative Recap
To own Ecolab, you need to believe in its role as a long term provider of essential water, hygiene and infection prevention solutions with pricing power and disciplined capital allocation. The latest analyst reaffirmation and modest uptick in short interest do not appear to materially change the near term focus on margin resilience as tariffs and cost pressures remain the key risk to watch.
Among the recent developments, Ecolab’s double A score from CDP for water and climate leadership stands out because it reinforces the company’s positioning in sustainability solutions, which ties directly into the One Ecolab growth initiative and its push for value based pricing and potential margin support.
Yet beneath the strong sustainability story, investors should also be aware that...
Read the full narrative on Ecolab (it's free!)
Ecolab's narrative projects $18.4 billion revenue and $2.8 billion earnings by 2028.
Uncover how Ecolab's forecasts yield a $294.71 fair value, a 8% upside to its current price.
Exploring Other Perspectives
Four members of the Simply Wall St Community currently value Ecolab between US$243.15 and US$294.71 per share, illustrating how far individual views can stretch. You can weigh those opinions against the tariff and cost pressure risks discussed earlier, and decide how they might affect Ecolab’s ability to protect margins and earnings over time.
Explore 4 other fair value estimates on Ecolab - why the stock might be worth 11% less than the current price!
Build Your Own Ecolab Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Ecolab research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
- Our free Ecolab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ecolab's overall financial health at a glance.
No Opportunity In Ecolab?
Our top stock finds are flying under the radar-for now. Get in early:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
- Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ecolab might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:ECL
Ecolab
Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Average dividend payer with acceptable track record.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Lundin-Backed: 10x High-Grade Copper-Gold Discovery + Billion-Pound Resource Anchor

A Capital Allocation Favorite with Structural Importance
Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%
Popular Narratives

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Investment Analysis (May 2026)
